Targeted Cancer Immune Therapy
Cancer has surpassed heart disease as the number one killer in the world, and standard cancer therapy such as radiation, chemotherapy, and surgery may have reached its plateau in further improving the outcome of treated patients. Biological therapies combined with other treatment approaches may be t...
| Συγγραφή απο Οργανισμό/Αρχή: | |
|---|---|
| Άλλοι συγγραφείς: | , , |
| Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
New York, NY :
Springer New York,
2009.
|
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Cytokine Immune Therapy
- Role of IL12 Family in Regulation of Antitumor Immune Response
- IL-18 in Regulation of Antitumor Immune Response and Clinical Application
- Interleukin-21 and Cancer Therapy
- IL-24 in Regulation of Antitumor Immune Response and in Signaling
- IL-28 and IL-29 in Regulation of Antitumor Immune Response and Induction of Tumor Regression
- Passive and Active Tumor Homing Cytokine Therapy
- Cell-based Immune Therapy
- New Strategies to Improve Tumor Cell Vaccine Therapy
- Modification of Dendritic Cells to Enhance Cancer Vaccine Potency
- Dendritic Cell Vaccines for Immunotherapy of Cancer: Challenges in Clinical Trials
- A “Toll Bridge” for Tumor-Specific T Cells
- Engineering Adult Stem Cells for Cancer Immunotherapy
- Animal Models for Evaluating Immune Responses of Human Effector Cells In Vivo
- Targeted Immune Therapy
- CD40 Stimulation and Antitumor Effects
- Immunocytokines: A Novel Approach to Cancer Immune Therapy
- Immune Escape: Role of Indoleamine 2,3-Dioxygenase in Tumor Tolerance
- Adoptive Transfer of T-Bodies: Toward an Effective Cancer Immunotherapy
- Targeting Toll-Like Receptor for the Induction of Immune and Antitumor Responses
- Manipulating TNF Receptors to Enhance Tumor Immunity for the Treatment of Cancer.
